In a June 29 decision, Judge Dickinson Debevoise of the U.S. District Court for the District of New Jersey upheld the patent protecting Pfizer's blood pressure medicine Accupril (quinapril hydrochloride) against Teva.
Consequently, the court issued an injunction blocking the approval of Teva's drug application until the February 2007 expiration of the company's patent.
Following the ruling, Teva announced its intention to appeal.
In another legal decision involving Accupril, Pfizer successfully obtained dismissal without prejudice of a declaratory action filed by another generic company, Apotex, against the Accupril formulation patent.
COPYRIGHT 2004 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2004 Gale Group
Home
A
8-Hour Bayer
